C4 Therapeutics (CCCC) Cash & Equivalents (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.87% |
| Dec 31, 2025 | 26.86% |
| Sep 30, 2025 | -24.76% |
| Jun 30, 2025 | 52.37% |
| Mar 31, 2025 | -7.58% |
| Dec 31, 2024 | -6.96% |
| Sep 30, 2024 | -18.42% |
| Jun 30, 2024 | -18.45% |
| Mar 31, 2024 | -29.17% |
| Dec 31, 2023 | 107.62% |
| Sep 30, 2023 | 35.85% |
| Jun 30, 2023 | -9.29% |
| Mar 31, 2023 | 66.28% |
| Dec 31, 2022 | -39.95% |
| Sep 30, 2022 | -13.52% |
| Jun 30, 2022 | 24.55% |
| Mar 31, 2022 | -39.57% |
| Dec 31, 2021 | -53.22% |
| Sep 30, 2021 | -42.11% |
| Jun 30, 2021 | 196.22% |
| Mar 31, 2021 | -47.77% |
| Dec 31, 2020 | 186.48% |
| Sep 30, 2020 | -41.07% |
| Jun 30, 2020 | 45.76% |
| Mar 31, 2020 | -18.44% |
| Dec 31, 2019 | -10.32% |